nodes	percent_of_prediction	percent_of_DWPC	metapath
Quazepam—Benzodiazepines—Midazolam—epilepsy syndrome	0.0684	0.266	CiPCiCtD
Quazepam—Benzodiazepines—Clonazepam—epilepsy syndrome	0.0684	0.266	CiPCiCtD
Quazepam—Benzodiazepines—Diazepam—epilepsy syndrome	0.0684	0.266	CiPCiCtD
Quazepam—Clonazepam—epilepsy syndrome	0.0649	0.357	CrCtD
Quazepam—Midazolam—epilepsy syndrome	0.0619	0.34	CrCtD
Quazepam—Diazepam—epilepsy syndrome	0.0552	0.303	CrCtD
Quazepam—Benzodiazepines—Clobazam—epilepsy syndrome	0.0518	0.202	CiPCiCtD
Quazepam—GABRD—epilepsy syndrome	0.0299	0.267	CbGaD
Quazepam—multiple sclerosis—Diazepam—epilepsy syndrome	0.0268	0.213	CpDpCtD
Quazepam—multiple sclerosis—Oxcarbazepine—epilepsy syndrome	0.0268	0.213	CpDpCtD
Quazepam—multiple sclerosis—Pregabalin—epilepsy syndrome	0.0228	0.181	CpDpCtD
Quazepam—GABRG2—epilepsy syndrome	0.0227	0.202	CbGaD
Quazepam—multiple sclerosis—Carbamazepine—epilepsy syndrome	0.0203	0.161	CpDpCtD
Quazepam—GABRB3—epilepsy syndrome	0.0183	0.163	CbGaD
Quazepam—GABRA5—epilepsy syndrome	0.0183	0.163	CbGaD
Quazepam—multiple sclerosis—Clonazepam—epilepsy syndrome	0.0162	0.129	CpDpCtD
Quazepam—GABRA1—epilepsy syndrome	0.0157	0.14	CbGaD
Quazepam—multiple sclerosis—Gabapentin—epilepsy syndrome	0.0131	0.104	CpDpCtD
Quazepam—CYP2C19—epilepsy syndrome	0.00736	0.0657	CbGaD
Quazepam—GABRR3—Midazolam—epilepsy syndrome	0.00412	0.0292	CbGbCtD
Quazepam—GABRR2—Midazolam—epilepsy syndrome	0.00412	0.0292	CbGbCtD
Quazepam—GABRR1—Midazolam—epilepsy syndrome	0.00412	0.0292	CbGbCtD
Quazepam—GABRR2—Diazepam—epilepsy syndrome	0.00396	0.028	CbGbCtD
Quazepam—GABRR1—Diazepam—epilepsy syndrome	0.00396	0.028	CbGbCtD
Quazepam—GABRR3—Diazepam—epilepsy syndrome	0.00396	0.028	CbGbCtD
Quazepam—Clotiazepam—Clonazepam—epilepsy syndrome	0.00379	0.0298	CrCrCtD
Quazepam—Clotiazepam—Midazolam—epilepsy syndrome	0.00362	0.0284	CrCrCtD
Quazepam—Clotiazepam—Diazepam—epilepsy syndrome	0.00322	0.0253	CrCrCtD
Quazepam—GABRP—Midazolam—epilepsy syndrome	0.00308	0.0218	CbGbCtD
Quazepam—GABRE—Midazolam—epilepsy syndrome	0.00298	0.0211	CbGbCtD
Quazepam—GABRP—Diazepam—epilepsy syndrome	0.00296	0.021	CbGbCtD
Quazepam—GABRG1—Midazolam—epilepsy syndrome	0.00288	0.0204	CbGbCtD
Quazepam—GABRD—Midazolam—epilepsy syndrome	0.00288	0.0204	CbGbCtD
Quazepam—GABRA3—Clonazepam—epilepsy syndrome	0.00287	0.0204	CbGbCtD
Quazepam—GABRE—Diazepam—epilepsy syndrome	0.00286	0.0203	CbGbCtD
Quazepam—GABRG3—Midazolam—epilepsy syndrome	0.00279	0.0198	CbGbCtD
Quazepam—GABRD—Diazepam—epilepsy syndrome	0.00277	0.0196	CbGbCtD
Quazepam—GABRG1—Diazepam—epilepsy syndrome	0.00277	0.0196	CbGbCtD
Quazepam—GABRB1—Midazolam—epilepsy syndrome	0.00271	0.0192	CbGbCtD
Quazepam—Ethyl loflazepate—Clonazepam—epilepsy syndrome	0.00269	0.0211	CrCrCtD
Quazepam—GABRG3—Diazepam—epilepsy syndrome	0.00268	0.019	CbGbCtD
Quazepam—GABRA5—Amobarbital—epilepsy syndrome	0.00266	0.0188	CbGbCtD
Quazepam—GABRG2—Clonazepam—epilepsy syndrome	0.00264	0.0187	CbGbCtD
Quazepam—GABRB1—Diazepam—epilepsy syndrome	0.0026	0.0184	CbGbCtD
Quazepam—Ethyl loflazepate—Midazolam—epilepsy syndrome	0.00256	0.0201	CrCrCtD
Quazepam—Cinolazepam—Midazolam—epilepsy syndrome	0.00256	0.0201	CrCrCtD
Quazepam—GABRA3—Amobarbital—epilepsy syndrome	0.00256	0.0181	CbGbCtD
Quazepam—GABRG2—Clobazam—epilepsy syndrome	0.00253	0.0179	CbGbCtD
Quazepam—Flunitrazepam—Clonazepam—epilepsy syndrome	0.00249	0.0195	CrCrCtD
Quazepam—GABRA2—Amobarbital—epilepsy syndrome	0.00247	0.0175	CbGbCtD
Quazepam—Flunitrazepam—Midazolam—epilepsy syndrome	0.00238	0.0186	CrCrCtD
Quazepam—Cinolazepam—Diazepam—epilepsy syndrome	0.00228	0.0179	CrCrCtD
Quazepam—Ethyl loflazepate—Diazepam—epilepsy syndrome	0.00228	0.0179	CrCrCtD
Quazepam—Flunitrazepam—Clobazam—epilepsy syndrome	0.00228	0.0179	CrCrCtD
Quazepam—Alprazolam—Clonazepam—epilepsy syndrome	0.00225	0.0176	CrCrCtD
Quazepam—Halazepam—Clonazepam—epilepsy syndrome	0.00225	0.0176	CrCrCtD
Quazepam—Triazolam—Clonazepam—epilepsy syndrome	0.00225	0.0176	CrCrCtD
Quazepam—Clonazepam—Midazolam—epilepsy syndrome	0.00222	0.0174	CrCrCtD
Quazepam—GABRA5—Primidone—epilepsy syndrome	0.00221	0.0157	CbGbCtD
Quazepam—GABRA1—Clonazepam—epilepsy syndrome	0.0022	0.0156	CbGbCtD
Quazepam—Estazolam—Clonazepam—epilepsy syndrome	0.00218	0.0171	CrCrCtD
Quazepam—Adinazolam—Midazolam—epilepsy syndrome	0.00214	0.0168	CrCrCtD
Quazepam—Alprazolam—Midazolam—epilepsy syndrome	0.00214	0.0168	CrCrCtD
Quazepam—Halazepam—Midazolam—epilepsy syndrome	0.00214	0.0168	CrCrCtD
Quazepam—Triazolam—Midazolam—epilepsy syndrome	0.00214	0.0168	CrCrCtD
Quazepam—GABRA3—Primidone—epilepsy syndrome	0.00213	0.0151	CbGbCtD
Quazepam—Flunitrazepam—Diazepam—epilepsy syndrome	0.00212	0.0166	CrCrCtD
Quazepam—Midazolam—Clonazepam—epilepsy syndrome	0.00211	0.0166	CrCrCtD
Quazepam—Flurazepam—Clonazepam—epilepsy syndrome	0.00211	0.0166	CrCrCtD
Quazepam—GABRA1—Clobazam—epilepsy syndrome	0.00211	0.0149	CbGbCtD
Quazepam—Estazolam—Midazolam—epilepsy syndrome	0.00208	0.0163	CrCrCtD
Quazepam—GABRA2—Primidone—epilepsy syndrome	0.00206	0.0146	CbGbCtD
Quazepam—Adinazolam—Clobazam—epilepsy syndrome	0.00206	0.0161	CrCrCtD
Quazepam—Halazepam—Clobazam—epilepsy syndrome	0.00206	0.0161	CrCrCtD
Quazepam—Alprazolam—Clobazam—epilepsy syndrome	0.00206	0.0161	CrCrCtD
Quazepam—Triazolam—Clobazam—epilepsy syndrome	0.00206	0.0161	CrCrCtD
Quazepam—Lorazepam—Clonazepam—epilepsy syndrome	0.00205	0.0161	CrCrCtD
Quazepam—Flurazepam—Midazolam—epilepsy syndrome	0.00202	0.0158	CrCrCtD
Quazepam—Estazolam—Clobazam—epilepsy syndrome	0.00199	0.0156	CrCrCtD
Quazepam—GABRB3—Propofol—epilepsy syndrome	0.00198	0.014	CbGbCtD
Quazepam—Clonazepam—Diazepam—epilepsy syndrome	0.00197	0.0155	CrCrCtD
Quazepam—GABRG2—Primidone—epilepsy syndrome	0.00196	0.0139	CbGbCtD
Quazepam—Lorazepam—Midazolam—epilepsy syndrome	0.00196	0.0154	CrCrCtD
Quazepam—GABRA1—Amobarbital—epilepsy syndrome	0.00196	0.0139	CbGbCtD
Quazepam—Midazolam—Clobazam—epilepsy syndrome	0.00193	0.0152	CrCrCtD
Quazepam—Flurazepam—Clobazam—epilepsy syndrome	0.00193	0.0152	CrCrCtD
Quazepam—Alprazolam—Diazepam—epilepsy syndrome	0.00191	0.015	CrCrCtD
Quazepam—Triazolam—Diazepam—epilepsy syndrome	0.00191	0.015	CrCrCtD
Quazepam—Halazepam—Diazepam—epilepsy syndrome	0.00191	0.015	CrCrCtD
Quazepam—Adinazolam—Diazepam—epilepsy syndrome	0.00191	0.015	CrCrCtD
Quazepam—Temazepam—Midazolam—epilepsy syndrome	0.0019	0.015	CrCrCtD
Quazepam—GABRB3—Midazolam—epilepsy syndrome	0.00187	0.0132	CbGbCtD
Quazepam—GABRA5—Midazolam—epilepsy syndrome	0.00187	0.0132	CbGbCtD
Quazepam—Estazolam—Diazepam—epilepsy syndrome	0.00185	0.0145	CrCrCtD
Quazepam—GABRA2—Propofol—epilepsy syndrome	0.00185	0.0131	CbGbCtD
Quazepam—Prazepam—Clonazepam—epilepsy syndrome	0.00184	0.0145	CrCrCtD
Quazepam—Fludiazepam—Clonazepam—epilepsy syndrome	0.00184	0.0145	CrCrCtD
Quazepam—Temazepam—Clobazam—epilepsy syndrome	0.00183	0.0143	CrCrCtD
Quazepam—GABRA3—Midazolam—epilepsy syndrome	0.0018	0.0128	CbGbCtD
Quazepam—Flurazepam—Diazepam—epilepsy syndrome	0.0018	0.0141	CrCrCtD
Quazepam—Midazolam—Diazepam—epilepsy syndrome	0.0018	0.0141	CrCrCtD
Quazepam—GABRA5—Diazepam—epilepsy syndrome	0.00179	0.0127	CbGbCtD
Quazepam—GABRB3—Diazepam—epilepsy syndrome	0.00179	0.0127	CbGbCtD
Quazepam—Fludiazepam—Midazolam—epilepsy syndrome	0.00176	0.0138	CrCrCtD
Quazepam—Prazepam—Midazolam—epilepsy syndrome	0.00176	0.0138	CrCrCtD
Quazepam—Delorazepam—Clonazepam—epilepsy syndrome	0.00176	0.0138	CrCrCtD
Quazepam—GABRG2—Propofol—epilepsy syndrome	0.00176	0.0124	CbGbCtD
Quazepam—Lorazepam—Diazepam—epilepsy syndrome	0.00175	0.0137	CrCrCtD
Quazepam—GABRA2—Midazolam—epilepsy syndrome	0.00174	0.0123	CbGbCtD
Quazepam—GABRA3—Diazepam—epilepsy syndrome	0.00173	0.0123	CbGbCtD
Quazepam—Temazepam—Diazepam—epilepsy syndrome	0.0017	0.0133	CrCrCtD
Quazepam—Fludiazepam—Clobazam—epilepsy syndrome	0.00169	0.0132	CrCrCtD
Quazepam—Prazepam—Clobazam—epilepsy syndrome	0.00169	0.0132	CrCrCtD
Quazepam—Diazepam—Clonazepam—epilepsy syndrome	0.00168	0.0132	CrCrCtD
Quazepam—Delorazepam—Midazolam—epilepsy syndrome	0.00168	0.0132	CrCrCtD
Quazepam—GABRA2—Diazepam—epilepsy syndrome	0.00167	0.0118	CbGbCtD
Quazepam—GABRG2—Midazolam—epilepsy syndrome	0.00165	0.0117	CbGbCtD
Quazepam—GABRA1—Primidone—epilepsy syndrome	0.00163	0.0115	CbGbCtD
Quazepam—Delorazepam—Clobazam—epilepsy syndrome	0.00161	0.0126	CrCrCtD
Quazepam—Diazepam—Midazolam—epilepsy syndrome	0.0016	0.0126	CrCrCtD
Quazepam—Diazepam—Oxcarbazepine—epilepsy syndrome	0.0016	0.0126	CrCrCtD
Quazepam—GABRG2—Diazepam—epilepsy syndrome	0.00159	0.0113	CbGbCtD
Quazepam—Prazepam—Diazepam—epilepsy syndrome	0.00157	0.0123	CrCrCtD
Quazepam—Fludiazepam—Diazepam—epilepsy syndrome	0.00157	0.0123	CrCrCtD
Quazepam—Diazepam—Clobazam—epilepsy syndrome	0.00154	0.0121	CrCrCtD
Quazepam—Delorazepam—Diazepam—epilepsy syndrome	0.00149	0.0117	CrCrCtD
Quazepam—GABRA1—Propofol—epilepsy syndrome	0.00146	0.0103	CbGbCtD
Quazepam—GABRA1—Phenobarbital—epilepsy syndrome	0.00139	0.00988	CbGbCtD
Quazepam—GABRA1—Midazolam—epilepsy syndrome	0.00138	0.00974	CbGbCtD
Quazepam—GABRA1—Diazepam—epilepsy syndrome	0.00132	0.00937	CbGbCtD
Quazepam—GABRG2—Topiramate—epilepsy syndrome	0.00113	0.00801	CbGbCtD
Quazepam—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00107	0.00757	CbGbCtD
Quazepam—CYP2C19—Felbamate—epilepsy syndrome	0.000994	0.00704	CbGbCtD
Quazepam—CYP2C19—Trimethadione—epilepsy syndrome	0.000994	0.00704	CbGbCtD
Quazepam—GABRA1—Topiramate—epilepsy syndrome	0.000941	0.00666	CbGbCtD
Quazepam—CYP2C19—Fosphenytoin—epilepsy syndrome	0.000934	0.00662	CbGbCtD
Quazepam—CYP2C9—Trimethadione—epilepsy syndrome	0.000826	0.00585	CbGbCtD
Quazepam—CYP2C19—Clobazam—epilepsy syndrome	0.00081	0.00574	CbGbCtD
Quazepam—CYP2C9—Fosphenytoin—epilepsy syndrome	0.000777	0.0055	CbGbCtD
Quazepam—CYP2C19—Carbamazepine—epilepsy syndrome	0.000671	0.00475	CbGbCtD
Quazepam—CYP2C19—Primidone—epilepsy syndrome	0.000627	0.00444	CbGbCtD
Quazepam—CYP2C19—Phenytoin—epilepsy syndrome	0.000602	0.00426	CbGbCtD
Quazepam—Withdrawal syndrome—Midazolam—epilepsy syndrome	0.000572	0.0296	CcSEcCtD
Quazepam—CYP2C19—Propofol—epilepsy syndrome	0.000561	0.00398	CbGbCtD
Quazepam—CYP2C9—Carbamazepine—epilepsy syndrome	0.000558	0.00395	CbGbCtD
Quazepam—CYP2C19—Phenobarbital—epilepsy syndrome	0.000537	0.0038	CbGbCtD
Quazepam—CYP2C9—Primidone—epilepsy syndrome	0.000521	0.00369	CbGbCtD
Quazepam—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.000517	0.00366	CbGbCtD
Quazepam—CYP2C19—Diazepam—epilepsy syndrome	0.000509	0.0036	CbGbCtD
Quazepam—CYP2C9—Phenytoin—epilepsy syndrome	0.0005	0.00354	CbGbCtD
Quazepam—CYP2C19—Zonisamide—epilepsy syndrome	0.000496	0.00352	CbGbCtD
Quazepam—CYP3A4—Trimethadione—epilepsy syndrome	0.00048	0.0034	CbGbCtD
Quazepam—CYP3A4—Felbamate—epilepsy syndrome	0.00048	0.0034	CbGbCtD
Quazepam—Thinking abnormal—Amobarbital—epilepsy syndrome	0.00048	0.0249	CcSEcCtD
Quazepam—CYP2C9—Propofol—epilepsy syndrome	0.000467	0.00331	CbGbCtD
Quazepam—CYP3A4—Fosphenytoin—epilepsy syndrome	0.000452	0.0032	CbGbCtD
Quazepam—CYP2C9—Phenobarbital—epilepsy syndrome	0.000446	0.00316	CbGbCtD
Quazepam—CYP2C9—Diazepam—epilepsy syndrome	0.000423	0.00299	CbGbCtD
Quazepam—CYP3A4—Clonazepam—epilepsy syndrome	0.000408	0.00289	CbGbCtD
Quazepam—CYP2C19—Valproic Acid—epilepsy syndrome	0.000401	0.00284	CbGbCtD
Quazepam—CYP3A4—Clobazam—epilepsy syndrome	0.000392	0.00277	CbGbCtD
Quazepam—Mental disability—Amobarbital—epilepsy syndrome	0.000381	0.0198	CcSEcCtD
Quazepam—CYP2C19—Topiramate—epilepsy syndrome	0.000362	0.00256	CbGbCtD
Quazepam—Thinking abnormal—Phenobarbital—epilepsy syndrome	0.00036	0.0187	CcSEcCtD
Quazepam—GABRG1—ganglion—epilepsy syndrome	0.00035	0.0404	CbGeAlD
Quazepam—CYP2C9—Valproic Acid—epilepsy syndrome	0.000333	0.00236	CbGbCtD
Quazepam—CYP3A4—Rufinamide—epilepsy syndrome	0.000333	0.00236	CbGbCtD
Quazepam—CYP3A4—Carbamazepine—epilepsy syndrome	0.000324	0.0023	CbGbCtD
Quazepam—Withdrawal syndrome—Pregabalin—epilepsy syndrome	0.000314	0.0163	CcSEcCtD
Quazepam—CYP3A4—Primidone—epilepsy syndrome	0.000303	0.00214	CbGbCtD
Quazepam—CYP3A4—Phenytoin—epilepsy syndrome	0.000291	0.00206	CbGbCtD
Quazepam—Mental disability—Phenobarbital—epilepsy syndrome	0.000286	0.0148	CcSEcCtD
Quazepam—CYP3A4—Propofol—epilepsy syndrome	0.000271	0.00192	CbGbCtD
Quazepam—Thinking abnormal—Propofol—epilepsy syndrome	0.000267	0.0138	CcSEcCtD
Quazepam—CYP3A4—Phenobarbital—epilepsy syndrome	0.000259	0.00184	CbGbCtD
Quazepam—CYP3A4—Acetazolamide—epilepsy syndrome	0.000259	0.00184	CbGbCtD
Quazepam—Thinking abnormal—Levetiracetam—epilepsy syndrome	0.000258	0.0134	CcSEcCtD
Quazepam—CYP3A4—Midazolam—epilepsy syndrome	0.000256	0.00181	CbGbCtD
Quazepam—Thinking abnormal—Fosphenytoin—epilepsy syndrome	0.000249	0.0129	CcSEcCtD
Quazepam—CYP3A4—Diazepam—epilepsy syndrome	0.000246	0.00174	CbGbCtD
Quazepam—Thinking abnormal—Vigabatrin—epilepsy syndrome	0.000242	0.0126	CcSEcCtD
Quazepam—CYP3A4—Zonisamide—epilepsy syndrome	0.00024	0.0017	CbGbCtD
Quazepam—Thinking abnormal—Diazepam—epilepsy syndrome	0.000239	0.0124	CcSEcCtD
Quazepam—Drowsiness—Primidone—epilepsy syndrome	0.000237	0.0123	CcSEcCtD
Quazepam—GABRA2—ganglion—epilepsy syndrome	0.000234	0.027	CbGeAlD
Quazepam—Thinking abnormal—Felbamate—epilepsy syndrome	0.000231	0.012	CcSEcCtD
Quazepam—Thinking abnormal—Phenytoin—epilepsy syndrome	0.000216	0.0112	CcSEcCtD
Quazepam—Thinking abnormal—Oxcarbazepine—epilepsy syndrome	0.000215	0.0112	CcSEcCtD
Quazepam—Mental disability—Propofol—epilepsy syndrome	0.000212	0.011	CcSEcCtD
Quazepam—Drowsiness—Trimethadione—epilepsy syndrome	0.000208	0.0108	CcSEcCtD
Quazepam—Thinking abnormal—Carbamazepine—epilepsy syndrome	0.000206	0.0107	CcSEcCtD
Quazepam—Mental disability—Levetiracetam—epilepsy syndrome	0.000205	0.0106	CcSEcCtD
Quazepam—Mental disability—Fosphenytoin—epilepsy syndrome	0.000197	0.0102	CcSEcCtD
Quazepam—CYP3A4—Valproic Acid—epilepsy syndrome	0.000194	0.00137	CbGbCtD
Quazepam—Mental disability—Vigabatrin—epilepsy syndrome	0.000192	0.00998	CcSEcCtD
Quazepam—Mental disability—Diazepam—epilepsy syndrome	0.000189	0.00983	CcSEcCtD
Quazepam—Drowsiness—Phenobarbital—epilepsy syndrome	0.000184	0.00956	CcSEcCtD
Quazepam—Mental disability—Felbamate—epilepsy syndrome	0.000183	0.00951	CcSEcCtD
Quazepam—GABRA2—hindbrain—epilepsy syndrome	0.000177	0.0205	CbGeAlD
Quazepam—GABRR1—forebrain—epilepsy syndrome	0.000175	0.0203	CbGeAlD
Quazepam—CYP3A4—Topiramate—epilepsy syndrome	0.000175	0.00124	CbGbCtD
Quazepam—Mental disability—Clonazepam—epilepsy syndrome	0.000173	0.00897	CcSEcCtD
Quazepam—Mental disability—Phenytoin—epilepsy syndrome	0.000172	0.00891	CcSEcCtD
Quazepam—GABRA1—hindbrain—epilepsy syndrome	0.000171	0.0198	CbGeAlD
Quazepam—Mental disability—Oxcarbazepine—epilepsy syndrome	0.000171	0.00886	CcSEcCtD
Quazepam—Drowsiness—Clobazam—epilepsy syndrome	0.000165	0.00855	CcSEcCtD
Quazepam—Mental disability—Carbamazepine—epilepsy syndrome	0.000164	0.00851	CcSEcCtD
Quazepam—Thinking abnormal—Valproic Acid—epilepsy syndrome	0.000159	0.00822	CcSEcCtD
Quazepam—GABRD—forebrain—epilepsy syndrome	0.000152	0.0176	CbGeAlD
Quazepam—Drowsiness—Acetazolamide—epilepsy syndrome	0.000147	0.00762	CcSEcCtD
Quazepam—GABRG1—forebrain—epilepsy syndrome	0.000147	0.017	CbGeAlD
Quazepam—Thinking abnormal—Pregabalin—epilepsy syndrome	0.000143	0.00743	CcSEcCtD
Quazepam—GABRA5—forebrain—epilepsy syndrome	0.000141	0.0164	CbGeAlD
Quazepam—GABRD—telencephalon—epilepsy syndrome	0.00014	0.0162	CbGeAlD
Quazepam—Somnolence—Amobarbital—epilepsy syndrome	0.000139	0.00722	CcSEcCtD
Quazepam—GABRG1—telencephalon—epilepsy syndrome	0.000135	0.0156	CbGeAlD
Quazepam—Somnolence—Primidone—epilepsy syndrome	0.000134	0.00696	CcSEcCtD
Quazepam—Drowsiness—Midazolam—epilepsy syndrome	0.000134	0.00693	CcSEcCtD
Quazepam—Drowsiness—Levetiracetam—epilepsy syndrome	0.000132	0.00684	CcSEcCtD
Quazepam—Thinking abnormal—Gabapentin—epilepsy syndrome	0.000131	0.00682	CcSEcCtD
Quazepam—GABRB1—telencephalon—epilepsy syndrome	0.000131	0.0151	CbGeAlD
Quazepam—Fatigue—Primidone—epilepsy syndrome	0.00013	0.00675	CcSEcCtD
Quazepam—GABRA5—telencephalon—epilepsy syndrome	0.00013	0.015	CbGeAlD
Quazepam—Mental disability—Valproic Acid—epilepsy syndrome	0.000126	0.00653	CcSEcCtD
Quazepam—Drowsiness—Vigabatrin—epilepsy syndrome	0.000124	0.00643	CcSEcCtD
Quazepam—Drowsiness—Diazepam—epilepsy syndrome	0.000122	0.00633	CcSEcCtD
Quazepam—GABRR3—head—epilepsy syndrome	0.00012	0.0139	CbGeAlD
Quazepam—Somnolence—Trimethadione—epilepsy syndrome	0.000118	0.00612	CcSEcCtD
Quazepam—Fatigue—Trimethadione—epilepsy syndrome	0.000114	0.00594	CcSEcCtD
Quazepam—GABRR3—nervous system—epilepsy syndrome	0.000114	0.0132	CbGeAlD
Quazepam—Mental disability—Pregabalin—epilepsy syndrome	0.000114	0.00591	CcSEcCtD
Quazepam—Drowsiness—Clonazepam—epilepsy syndrome	0.000112	0.00578	CcSEcCtD
Quazepam—Drowsiness—Phenytoin—epilepsy syndrome	0.000111	0.00574	CcSEcCtD
Quazepam—Thinking abnormal—Topiramate—epilepsy syndrome	0.000111	0.00574	CcSEcCtD
Quazepam—Dry mouth—Lacosamide—epilepsy syndrome	0.000111	0.00573	CcSEcCtD
Quazepam—GABRD—medulla oblongata—epilepsy syndrome	0.00011	0.0127	CbGeAlD
Quazepam—Asthenia—Primidone—epilepsy syndrome	0.000108	0.00561	CcSEcCtD
Quazepam—GABRG2—forebrain—epilepsy syndrome	0.000107	0.0124	CbGeAlD
Quazepam—Dry mouth—Clobazam—epilepsy syndrome	0.000107	0.00556	CcSEcCtD
Quazepam—GABRG1—medulla oblongata—epilepsy syndrome	0.000106	0.0122	CbGeAlD
Quazepam—Drowsiness—Carbamazepine—epilepsy syndrome	0.000106	0.00548	CcSEcCtD
Quazepam—GABRG3—head—epilepsy syndrome	0.000105	0.0122	CbGeAlD
Quazepam—Somnolence—Phenobarbital—epilepsy syndrome	0.000105	0.00542	CcSEcCtD
Quazepam—Mental disability—Gabapentin—epilepsy syndrome	0.000104	0.00542	CcSEcCtD
Quazepam—GABRR2—head—epilepsy syndrome	0.000104	0.0121	CbGeAlD
Quazepam—Dizziness—Amobarbital—epilepsy syndrome	0.000104	0.00537	CcSEcCtD
Quazepam—GABRB1—medulla oblongata—epilepsy syndrome	0.000103	0.0119	CbGeAlD
Quazepam—Somnolence—Rufinamide—epilepsy syndrome	0.000103	0.00532	CcSEcCtD
Quazepam—Drowsiness—Lamotrigine—epilepsy syndrome	0.000102	0.0053	CcSEcCtD
Quazepam—GABRA2—brainstem—epilepsy syndrome	0.000102	0.0117	CbGeAlD
Quazepam—Dyspepsia—Rufinamide—epilepsy syndrome	0.000102	0.00527	CcSEcCtD
Quazepam—GABRD—midbrain—epilepsy syndrome	0.000101	0.0116	CbGeAlD
Quazepam—GABRR1—head—epilepsy syndrome	0.0001	0.0116	CbGeAlD
Quazepam—GABRG3—nervous system—epilepsy syndrome	9.99e-05	0.0115	CbGeAlD
Quazepam—Dizziness—Primidone—epilepsy syndrome	9.98e-05	0.00517	CcSEcCtD
Quazepam—Fatigue—Rufinamide—epilepsy syndrome	9.95e-05	0.00516	CcSEcCtD
Quazepam—GABRR2—nervous system—epilepsy syndrome	9.89e-05	0.0114	CbGeAlD
Quazepam—GABRG2—telencephalon—epilepsy syndrome	9.87e-05	0.0114	CbGeAlD
Quazepam—GABRA1—brainstem—epilepsy syndrome	9.82e-05	0.0114	CbGeAlD
Quazepam—Headache—Amobarbital—epilepsy syndrome	9.81e-05	0.00509	CcSEcCtD
Quazepam—GABRA2—forebrain—epilepsy syndrome	9.81e-05	0.0113	CbGeAlD
Quazepam—GABRG1—midbrain—epilepsy syndrome	9.69e-05	0.0112	CbGeAlD
Quazepam—Somnolence—Lacosamide—epilepsy syndrome	9.63e-05	0.005	CcSEcCtD
Quazepam—GABRG3—central nervous system—epilepsy syndrome	9.62e-05	0.0111	CbGeAlD
Quazepam—Dyspepsia—Lacosamide—epilepsy syndrome	9.54e-05	0.00495	CcSEcCtD
Quazepam—Asthenia—Trimethadione—epilepsy syndrome	9.52e-05	0.00494	CcSEcCtD
Quazepam—GABRR1—nervous system—epilepsy syndrome	9.52e-05	0.011	CbGeAlD
Quazepam—GABRA1—forebrain—epilepsy syndrome	9.48e-05	0.011	CbGeAlD
Quazepam—Headache—Primidone—epilepsy syndrome	9.45e-05	0.0049	CcSEcCtD
Quazepam—GABRG1—spinal cord—epilepsy syndrome	9.45e-05	0.0109	CbGeAlD
Quazepam—GABRB1—midbrain—epilepsy syndrome	9.39e-05	0.0109	CbGeAlD
Quazepam—Somnolence—Clobazam—epilepsy syndrome	9.35e-05	0.00485	CcSEcCtD
Quazepam—Fatigue—Lacosamide—epilepsy syndrome	9.34e-05	0.00484	CcSEcCtD
Quazepam—GABRR2—cerebellum—epilepsy syndrome	9.3e-05	0.0108	CbGeAlD
Quazepam—GABRR1—central nervous system—epilepsy syndrome	9.16e-05	0.0106	CbGeAlD
Quazepam—GABRB1—spinal cord—epilepsy syndrome	9.16e-05	0.0106	CbGeAlD
Quazepam—Fatigue—Clobazam—epilepsy syndrome	9.07e-05	0.0047	CcSEcCtD
Quazepam—GABRA2—telencephalon—epilepsy syndrome	9.02e-05	0.0104	CbGeAlD
Quazepam—Dry mouth—Propofol—epilepsy syndrome	8.88e-05	0.00461	CcSEcCtD
Quazepam—Mental disability—Topiramate—epilepsy syndrome	8.79e-05	0.00456	CcSEcCtD
Quazepam—GABRD—head—epilepsy syndrome	8.72e-05	0.0101	CbGeAlD
Quazepam—GABRA1—telencephalon—epilepsy syndrome	8.72e-05	0.0101	CbGeAlD
Quazepam—Dry mouth—Midazolam—epilepsy syndrome	8.69e-05	0.00451	CcSEcCtD
Quazepam—GABRG1—head—epilepsy syndrome	8.4e-05	0.00971	CbGeAlD
Quazepam—Somnolence—Acetazolamide—epilepsy syndrome	8.33e-05	0.00432	CcSEcCtD
Quazepam—Headache—Trimethadione—epilepsy syndrome	8.32e-05	0.00431	CcSEcCtD
Quazepam—Dry mouth—Fosphenytoin—epilepsy syndrome	8.28e-05	0.0043	CcSEcCtD
Quazepam—Asthenia—Rufinamide—epilepsy syndrome	8.28e-05	0.00429	CcSEcCtD
Quazepam—GABRD—nervous system—epilepsy syndrome	8.27e-05	0.00956	CbGeAlD
Quazepam—Dyspepsia—Acetazolamide—epilepsy syndrome	8.25e-05	0.00428	CcSEcCtD
Quazepam—GABRB3—forebrain—epilepsy syndrome	8.24e-05	0.00953	CbGeAlD
Quazepam—GABRB1—head—epilepsy syndrome	8.14e-05	0.00941	CbGeAlD
Quazepam—Drowsiness—Valproic Acid—epilepsy syndrome	8.12e-05	0.00421	CcSEcCtD
Quazepam—GABRA5—head—epilepsy syndrome	8.1e-05	0.00936	CbGeAlD
Quazepam—Fatigue—Acetazolamide—epilepsy syndrome	8.08e-05	0.00419	CcSEcCtD
Quazepam—GABRD—central nervous system—epilepsy syndrome	7.96e-05	0.00921	CbGeAlD
Quazepam—GABRG1—nervous system—epilepsy syndrome	7.96e-05	0.0092	CbGeAlD
Quazepam—Dry mouth—Diazepam—epilepsy syndrome	7.95e-05	0.00412	CcSEcCtD
Quazepam—GABRD—cerebellum—epilepsy syndrome	7.78e-05	0.009	CbGeAlD
Quazepam—Asthenia—Lacosamide—epilepsy syndrome	7.77e-05	0.00403	CcSEcCtD
Quazepam—Dizziness—Phenobarbital—epilepsy syndrome	7.77e-05	0.00403	CcSEcCtD
Quazepam—GABRG2—medulla oblongata—epilepsy syndrome	7.76e-05	0.00897	CbGeAlD
Quazepam—Somnolence—Propofol—epilepsy syndrome	7.74e-05	0.00401	CcSEcCtD
Quazepam—GABRB1—nervous system—epilepsy syndrome	7.72e-05	0.00892	CbGeAlD
Quazepam—Dry mouth—Felbamate—epilepsy syndrome	7.69e-05	0.00399	CcSEcCtD
Quazepam—GABRA5—nervous system—epilepsy syndrome	7.68e-05	0.00888	CbGeAlD
Quazepam—GABRG1—central nervous system—epilepsy syndrome	7.67e-05	0.00886	CbGeAlD
Quazepam—GABRG3—brain—epilepsy syndrome	7.63e-05	0.00883	CbGeAlD
Quazepam—Dizziness—Rufinamide—epilepsy syndrome	7.63e-05	0.00396	CcSEcCtD
Quazepam—GABRB3—telencephalon—epilepsy syndrome	7.58e-05	0.00876	CbGeAlD
Quazepam—Somnolence—Midazolam—epilepsy syndrome	7.57e-05	0.00393	CcSEcCtD
Quazepam—Asthenia—Clobazam—epilepsy syndrome	7.54e-05	0.00391	CcSEcCtD
Quazepam—GABRA3—head—epilepsy syndrome	7.54e-05	0.00872	CbGeAlD
Quazepam—Dry mouth—Zonisamide—epilepsy syndrome	7.53e-05	0.0039	CcSEcCtD
Quazepam—Fatigue—Propofol—epilepsy syndrome	7.51e-05	0.00389	CcSEcCtD
Quazepam—Dyspepsia—Midazolam—epilepsy syndrome	7.5e-05	0.00389	CcSEcCtD
Quazepam—GABRG1—cerebellum—epilepsy syndrome	7.49e-05	0.00866	CbGeAlD
Quazepam—Somnolence—Levetiracetam—epilepsy syndrome	7.48e-05	0.00388	CcSEcCtD
Quazepam—GABRB1—central nervous system—epilepsy syndrome	7.43e-05	0.00859	CbGeAlD
Quazepam—Dyspepsia—Levetiracetam—epilepsy syndrome	7.4e-05	0.00384	CcSEcCtD
Quazepam—GABRA5—central nervous system—epilepsy syndrome	7.39e-05	0.00855	CbGeAlD
Quazepam—Headache—Phenobarbital—epilepsy syndrome	7.36e-05	0.00382	CcSEcCtD
Quazepam—Fatigue—Midazolam—epilepsy syndrome	7.34e-05	0.00381	CcSEcCtD
Quazepam—GABRP—head—epilepsy syndrome	7.3e-05	0.00843	CbGeAlD
Quazepam—GABRR1—brain—epilepsy syndrome	7.28e-05	0.00841	CbGeAlD
Quazepam—GABRB1—cerebellum—epilepsy syndrome	7.27e-05	0.0084	CbGeAlD
Quazepam—Dry mouth—Clonazepam—epilepsy syndrome	7.26e-05	0.00376	CcSEcCtD
Quazepam—Fatigue—Levetiracetam—epilepsy syndrome	7.25e-05	0.00376	CcSEcCtD
Quazepam—Headache—Rufinamide—epilepsy syndrome	7.23e-05	0.00375	CcSEcCtD
Quazepam—Somnolence—Fosphenytoin—epilepsy syndrome	7.22e-05	0.00374	CcSEcCtD
Quazepam—Dry mouth—Phenytoin—epilepsy syndrome	7.21e-05	0.00374	CcSEcCtD
Quazepam—Dry mouth—Oxcarbazepine—epilepsy syndrome	7.17e-05	0.00372	CcSEcCtD
Quazepam—Dizziness—Lacosamide—epilepsy syndrome	7.17e-05	0.00372	CcSEcCtD
Quazepam—GABRA3—nervous system—epilepsy syndrome	7.15e-05	0.00826	CbGeAlD
Quazepam—Dyspepsia—Fosphenytoin—epilepsy syndrome	7.15e-05	0.00371	CcSEcCtD
Quazepam—GABRG2—midbrain—epilepsy syndrome	7.09e-05	0.00819	CbGeAlD
Quazepam—Somnolence—Vigabatrin—epilepsy syndrome	7.03e-05	0.00365	CcSEcCtD
Quazepam—Dyspepsia—Vigabatrin—epilepsy syndrome	6.97e-05	0.00361	CcSEcCtD
Quazepam—Dizziness—Clobazam—epilepsy syndrome	6.95e-05	0.00361	CcSEcCtD
Quazepam—Somnolence—Diazepam—epilepsy syndrome	6.93e-05	0.00359	CcSEcCtD
Quazepam—GABRG2—spinal cord—epilepsy syndrome	6.92e-05	0.00799	CbGeAlD
Quazepam—GABRA3—central nervous system—epilepsy syndrome	6.88e-05	0.00796	CbGeAlD
Quazepam—Dry mouth—Carbamazepine—epilepsy syndrome	6.88e-05	0.00357	CcSEcCtD
Quazepam—Dyspepsia—Diazepam—epilepsy syndrome	6.86e-05	0.00356	CcSEcCtD
Quazepam—GABRA1—medulla oblongata—epilepsy syndrome	6.85e-05	0.00792	CbGeAlD
Quazepam—Fatigue—Vigabatrin—epilepsy syndrome	6.82e-05	0.00354	CcSEcCtD
Quazepam—Headache—Lacosamide—epilepsy syndrome	6.79e-05	0.00352	CcSEcCtD
Quazepam—Drowsiness—Gabapentin—epilepsy syndrome	6.73e-05	0.00349	CcSEcCtD
Quazepam—Asthenia—Acetazolamide—epilepsy syndrome	6.72e-05	0.00349	CcSEcCtD
Quazepam—Fatigue—Diazepam—epilepsy syndrome	6.72e-05	0.00348	CcSEcCtD
Quazepam—Somnolence—Felbamate—epilepsy syndrome	6.7e-05	0.00348	CcSEcCtD
Quazepam—Dry mouth—Lamotrigine—epilepsy syndrome	6.65e-05	0.00345	CcSEcCtD
Quazepam—Dyspepsia—Felbamate—epilepsy syndrome	6.64e-05	0.00344	CcSEcCtD
Quazepam—Headache—Clobazam—epilepsy syndrome	6.59e-05	0.00342	CcSEcCtD
Quazepam—Somnolence—Zonisamide—epilepsy syndrome	6.56e-05	0.0034	CcSEcCtD
Quazepam—Fatigue—Felbamate—epilepsy syndrome	6.5e-05	0.00337	CcSEcCtD
Quazepam—Dyspepsia—Zonisamide—epilepsy syndrome	6.5e-05	0.00337	CcSEcCtD
Quazepam—Fatigue—Zonisamide—epilepsy syndrome	6.36e-05	0.0033	CcSEcCtD
Quazepam—Somnolence—Clonazepam—epilepsy syndrome	6.32e-05	0.00328	CcSEcCtD
Quazepam—GABRD—brain—epilepsy syndrome	6.32e-05	0.00731	CbGeAlD
Quazepam—Somnolence—Phenytoin—epilepsy syndrome	6.28e-05	0.00326	CcSEcCtD
Quazepam—Dyspepsia—Clonazepam—epilepsy syndrome	6.26e-05	0.00325	CcSEcCtD
Quazepam—GABRA1—midbrain—epilepsy syndrome	6.26e-05	0.00724	CbGeAlD
Quazepam—Somnolence—Oxcarbazepine—epilepsy syndrome	6.25e-05	0.00324	CcSEcCtD
Quazepam—Asthenia—Propofol—epilepsy syndrome	6.25e-05	0.00324	CcSEcCtD
Quazepam—Dyspepsia—Phenytoin—epilepsy syndrome	6.22e-05	0.00323	CcSEcCtD
Quazepam—Dizziness—Acetazolamide—epilepsy syndrome	6.2e-05	0.00321	CcSEcCtD
Quazepam—Dyspepsia—Oxcarbazepine—epilepsy syndrome	6.19e-05	0.00321	CcSEcCtD
Quazepam—GABRG2—head—epilepsy syndrome	6.15e-05	0.00711	CbGeAlD
Quazepam—Fatigue—Clonazepam—epilepsy syndrome	6.13e-05	0.00318	CcSEcCtD
Quazepam—Asthenia—Midazolam—epilepsy syndrome	6.11e-05	0.00317	CcSEcCtD
Quazepam—GABRA1—spinal cord—epilepsy syndrome	6.11e-05	0.00706	CbGeAlD
Quazepam—Fatigue—Phenytoin—epilepsy syndrome	6.09e-05	0.00316	CcSEcCtD
Quazepam—GABRG1—brain—epilepsy syndrome	6.09e-05	0.00703	CbGeAlD
Quazepam—Fatigue—Oxcarbazepine—epilepsy syndrome	6.06e-05	0.00314	CcSEcCtD
Quazepam—Asthenia—Levetiracetam—epilepsy syndrome	6.03e-05	0.00313	CcSEcCtD
Quazepam—Somnolence—Carbamazepine—epilepsy syndrome	6e-05	0.00311	CcSEcCtD
Quazepam—GABRB3—medulla oblongata—epilepsy syndrome	5.96e-05	0.00689	CbGeAlD
Quazepam—Dyspepsia—Carbamazepine—epilepsy syndrome	5.94e-05	0.00308	CcSEcCtD
Quazepam—GABRB1—brain—epilepsy syndrome	5.9e-05	0.00682	CbGeAlD
Quazepam—Headache—Acetazolamide—epilepsy syndrome	5.87e-05	0.00305	CcSEcCtD
Quazepam—GABRA5—brain—epilepsy syndrome	5.87e-05	0.00679	CbGeAlD
Quazepam—GABRG2—nervous system—epilepsy syndrome	5.83e-05	0.00674	CbGeAlD
Quazepam—Asthenia—Fosphenytoin—epilepsy syndrome	5.82e-05	0.00302	CcSEcCtD
Quazepam—Fatigue—Carbamazepine—epilepsy syndrome	5.81e-05	0.00302	CcSEcCtD
Quazepam—Somnolence—Lamotrigine—epilepsy syndrome	5.79e-05	0.00301	CcSEcCtD
Quazepam—Dizziness—Propofol—epilepsy syndrome	5.76e-05	0.00299	CcSEcCtD
Quazepam—Dyspepsia—Lamotrigine—epilepsy syndrome	5.74e-05	0.00298	CcSEcCtD
Quazepam—Asthenia—Vigabatrin—epilepsy syndrome	5.68e-05	0.00294	CcSEcCtD
Quazepam—Dizziness—Midazolam—epilepsy syndrome	5.63e-05	0.00292	CcSEcCtD
Quazepam—Fatigue—Lamotrigine—epilepsy syndrome	5.62e-05	0.00291	CcSEcCtD
Quazepam—GABRA2—head—epilepsy syndrome	5.62e-05	0.00649	CbGeAlD
Quazepam—GABRG2—central nervous system—epilepsy syndrome	5.61e-05	0.00649	CbGeAlD
Quazepam—Asthenia—Diazepam—epilepsy syndrome	5.59e-05	0.0029	CcSEcCtD
Quazepam—GABRE—head—epilepsy syndrome	5.57e-05	0.00644	CbGeAlD
Quazepam—Dizziness—Levetiracetam—epilepsy syndrome	5.56e-05	0.00288	CcSEcCtD
Quazepam—GABRG2—cerebellum—epilepsy syndrome	5.48e-05	0.00634	CbGeAlD
Quazepam—GABRA3—brain—epilepsy syndrome	5.46e-05	0.00632	CbGeAlD
Quazepam—Headache—Propofol—epilepsy syndrome	5.45e-05	0.00283	CcSEcCtD
Quazepam—GABRB3—midbrain—epilepsy syndrome	5.44e-05	0.00629	CbGeAlD
Quazepam—GABRA1—head—epilepsy syndrome	5.43e-05	0.00627	CbGeAlD
Quazepam—Asthenia—Felbamate—epilepsy syndrome	5.41e-05	0.00281	CcSEcCtD
Quazepam—Dizziness—Fosphenytoin—epilepsy syndrome	5.37e-05	0.00278	CcSEcCtD
Quazepam—Headache—Midazolam—epilepsy syndrome	5.34e-05	0.00277	CcSEcCtD
Quazepam—GABRA2—nervous system—epilepsy syndrome	5.32e-05	0.00615	CbGeAlD
Quazepam—GABRB3—spinal cord—epilepsy syndrome	5.31e-05	0.00614	CbGeAlD
Quazepam—Asthenia—Zonisamide—epilepsy syndrome	5.3e-05	0.00275	CcSEcCtD
Quazepam—Dry mouth—Valproic Acid—epilepsy syndrome	5.28e-05	0.00274	CcSEcCtD
Quazepam—GABRE—nervous system—epilepsy syndrome	5.28e-05	0.0061	CbGeAlD
Quazepam—Headache—Levetiracetam—epilepsy syndrome	5.27e-05	0.00273	CcSEcCtD
Quazepam—Dizziness—Vigabatrin—epilepsy syndrome	5.23e-05	0.00271	CcSEcCtD
Quazepam—Dizziness—Diazepam—epilepsy syndrome	5.15e-05	0.00267	CcSEcCtD
Quazepam—GABRA1—nervous system—epilepsy syndrome	5.15e-05	0.00595	CbGeAlD
Quazepam—GABRA2—central nervous system—epilepsy syndrome	5.13e-05	0.00593	CbGeAlD
Quazepam—Asthenia—Clonazepam—epilepsy syndrome	5.1e-05	0.00265	CcSEcCtD
Quazepam—Headache—Fosphenytoin—epilepsy syndrome	5.09e-05	0.00264	CcSEcCtD
Quazepam—GABRE—central nervous system—epilepsy syndrome	5.08e-05	0.00588	CbGeAlD
Quazepam—Asthenia—Phenytoin—epilepsy syndrome	5.07e-05	0.00263	CcSEcCtD
Quazepam—Asthenia—Oxcarbazepine—epilepsy syndrome	5.04e-05	0.00261	CcSEcCtD
Quazepam—GABRA2—cerebellum—epilepsy syndrome	5.01e-05	0.00579	CbGeAlD
Quazepam—Dizziness—Felbamate—epilepsy syndrome	4.99e-05	0.00259	CcSEcCtD
Quazepam—Headache—Vigabatrin—epilepsy syndrome	4.96e-05	0.00257	CcSEcCtD
Quazepam—GABRA1—central nervous system—epilepsy syndrome	4.95e-05	0.00573	CbGeAlD
Quazepam—Dizziness—Zonisamide—epilepsy syndrome	4.88e-05	0.00253	CcSEcCtD
Quazepam—Headache—Diazepam—epilepsy syndrome	4.88e-05	0.00253	CcSEcCtD
Quazepam—GABRA1—cerebellum—epilepsy syndrome	4.84e-05	0.0056	CbGeAlD
Quazepam—Asthenia—Carbamazepine—epilepsy syndrome	4.84e-05	0.00251	CcSEcCtD
Quazepam—Dry mouth—Pregabalin—epilepsy syndrome	4.78e-05	0.00248	CcSEcCtD
Quazepam—Headache—Felbamate—epilepsy syndrome	4.72e-05	0.00245	CcSEcCtD
Quazepam—GABRB3—head—epilepsy syndrome	4.72e-05	0.00546	CbGeAlD
Quazepam—Dizziness—Clonazepam—epilepsy syndrome	4.7e-05	0.00244	CcSEcCtD
Quazepam—Asthenia—Lamotrigine—epilepsy syndrome	4.68e-05	0.00243	CcSEcCtD
Quazepam—Dizziness—Phenytoin—epilepsy syndrome	4.67e-05	0.00242	CcSEcCtD
Quazepam—Dizziness—Oxcarbazepine—epilepsy syndrome	4.65e-05	0.00241	CcSEcCtD
Quazepam—Headache—Zonisamide—epilepsy syndrome	4.62e-05	0.0024	CcSEcCtD
Quazepam—Somnolence—Valproic Acid—epilepsy syndrome	4.6e-05	0.00239	CcSEcCtD
Quazepam—Dyspepsia—Valproic Acid—epilepsy syndrome	4.56e-05	0.00236	CcSEcCtD
Quazepam—GABRB3—nervous system—epilepsy syndrome	4.48e-05	0.00517	CbGeAlD
Quazepam—Fatigue—Valproic Acid—epilepsy syndrome	4.47e-05	0.00232	CcSEcCtD
Quazepam—Dizziness—Carbamazepine—epilepsy syndrome	4.46e-05	0.00231	CcSEcCtD
Quazepam—Headache—Clonazepam—epilepsy syndrome	4.46e-05	0.00231	CcSEcCtD
Quazepam—GABRG2—brain—epilepsy syndrome	4.45e-05	0.00515	CbGeAlD
Quazepam—Headache—Phenytoin—epilepsy syndrome	4.43e-05	0.0023	CcSEcCtD
Quazepam—Headache—Oxcarbazepine—epilepsy syndrome	4.4e-05	0.00228	CcSEcCtD
Quazepam—Dry mouth—Gabapentin—epilepsy syndrome	4.38e-05	0.00227	CcSEcCtD
Quazepam—Dizziness—Lamotrigine—epilepsy syndrome	4.31e-05	0.00224	CcSEcCtD
Quazepam—GABRB3—central nervous system—epilepsy syndrome	4.31e-05	0.00498	CbGeAlD
Quazepam—Headache—Carbamazepine—epilepsy syndrome	4.22e-05	0.00219	CcSEcCtD
Quazepam—GABRB3—cerebellum—epilepsy syndrome	4.21e-05	0.00487	CbGeAlD
Quazepam—Somnolence—Pregabalin—epilepsy syndrome	4.16e-05	0.00216	CcSEcCtD
Quazepam—Headache—Lamotrigine—epilepsy syndrome	4.08e-05	0.00212	CcSEcCtD
Quazepam—GABRA2—brain—epilepsy syndrome	4.07e-05	0.0047	CbGeAlD
Quazepam—Fatigue—Pregabalin—epilepsy syndrome	4.04e-05	0.00209	CcSEcCtD
Quazepam—GABRE—brain—epilepsy syndrome	4.04e-05	0.00466	CbGeAlD
Quazepam—GABRA1—brain—epilepsy syndrome	3.93e-05	0.00455	CbGeAlD
Quazepam—Somnolence—Gabapentin—epilepsy syndrome	3.82e-05	0.00198	CcSEcCtD
Quazepam—Dyspepsia—Gabapentin—epilepsy syndrome	3.78e-05	0.00196	CcSEcCtD
Quazepam—Asthenia—Valproic Acid—epilepsy syndrome	3.72e-05	0.00193	CcSEcCtD
Quazepam—Fatigue—Gabapentin—epilepsy syndrome	3.7e-05	0.00192	CcSEcCtD
Quazepam—Dry mouth—Topiramate—epilepsy syndrome	3.69e-05	0.00191	CcSEcCtD
Quazepam—Dizziness—Valproic Acid—epilepsy syndrome	3.43e-05	0.00178	CcSEcCtD
Quazepam—GABRB3—brain—epilepsy syndrome	3.42e-05	0.00395	CbGeAlD
Quazepam—Asthenia—Pregabalin—epilepsy syndrome	3.36e-05	0.00174	CcSEcCtD
Quazepam—Headache—Valproic Acid—epilepsy syndrome	3.24e-05	0.00168	CcSEcCtD
Quazepam—Somnolence—Topiramate—epilepsy syndrome	3.21e-05	0.00167	CcSEcCtD
Quazepam—Dyspepsia—Topiramate—epilepsy syndrome	3.18e-05	0.00165	CcSEcCtD
Quazepam—Fatigue—Topiramate—epilepsy syndrome	3.11e-05	0.00162	CcSEcCtD
Quazepam—Dizziness—Pregabalin—epilepsy syndrome	3.1e-05	0.00161	CcSEcCtD
Quazepam—Asthenia—Gabapentin—epilepsy syndrome	3.08e-05	0.0016	CcSEcCtD
Quazepam—Headache—Pregabalin—epilepsy syndrome	2.93e-05	0.00152	CcSEcCtD
Quazepam—Dizziness—Gabapentin—epilepsy syndrome	2.84e-05	0.00147	CcSEcCtD
Quazepam—Headache—Gabapentin—epilepsy syndrome	2.69e-05	0.00139	CcSEcCtD
Quazepam—Asthenia—Topiramate—epilepsy syndrome	2.59e-05	0.00134	CcSEcCtD
Quazepam—Clotiazepam—GABRD—epilepsy syndrome	2.48e-05	0.0217	CrCbGaD
Quazepam—Lorazepam—GABRG2—epilepsy syndrome	2.41e-05	0.0211	CrCbGaD
Quazepam—Dizziness—Topiramate—epilepsy syndrome	2.39e-05	0.00124	CcSEcCtD
Quazepam—CYP3A4—nervous system—epilepsy syndrome	2.29e-05	0.00265	CbGeAlD
Quazepam—Cinolazepam—GABRD—epilepsy syndrome	2.28e-05	0.02	CrCbGaD
Quazepam—Headache—Topiramate—epilepsy syndrome	2.26e-05	0.00117	CcSEcCtD
Quazepam—CYP3A4—central nervous system—epilepsy syndrome	2.21e-05	0.00255	CbGeAlD
Quazepam—Clonazepam—GABRG2—epilepsy syndrome	2.02e-05	0.0177	CrCbGaD
Quazepam—Estazolam—GABRD—epilepsy syndrome	2e-05	0.0175	CrCbGaD
Quazepam—Halazepam—GABRD—epilepsy syndrome	1.95e-05	0.017	CrCbGaD
Quazepam—Lorazepam—GABRB3—epilepsy syndrome	1.94e-05	0.0169	CrCbGaD
Quazepam—Adinazolam—GABRD—epilepsy syndrome	1.91e-05	0.0167	CrCbGaD
Quazepam—Fludiazepam—GABRD—epilepsy syndrome	1.89e-05	0.0165	CrCbGaD
Quazepam—Clotiazepam—GABRG2—epilepsy syndrome	1.88e-05	0.0164	CrCbGaD
Quazepam—Prazepam—GABRD—epilepsy syndrome	1.84e-05	0.0161	CrCbGaD
Quazepam—Alprazolam—GABRG2—epilepsy syndrome	1.77e-05	0.0155	CrCbGaD
Quazepam—Cinolazepam—GABRG2—epilepsy syndrome	1.73e-05	0.0151	CrCbGaD
Quazepam—Flurazepam—GABRD—epilepsy syndrome	1.72e-05	0.0151	CrCbGaD
Quazepam—Triazolam—GABRD—epilepsy syndrome	1.72e-05	0.015	CrCbGaD
Quazepam—Lorazepam—GABRA1—epilepsy syndrome	1.66e-05	0.0145	CrCbGaD
Quazepam—Temazepam—GABRD—epilepsy syndrome	1.64e-05	0.0144	CrCbGaD
Quazepam—Midazolam—GABRD—epilepsy syndrome	1.59e-05	0.014	CrCbGaD
Quazepam—Estazolam—GABRG2—epilepsy syndrome	1.52e-05	0.0133	CrCbGaD
Quazepam—Clotiazepam—GABRA5—epilepsy syndrome	1.51e-05	0.0132	CrCbGaD
Quazepam—Clotiazepam—GABRB3—epilepsy syndrome	1.51e-05	0.0132	CrCbGaD
Quazepam—Halazepam—GABRG2—epilepsy syndrome	1.48e-05	0.0129	CrCbGaD
Quazepam—Adinazolam—GABRG2—epilepsy syndrome	1.45e-05	0.0127	CrCbGaD
Quazepam—Fludiazepam—GABRG2—epilepsy syndrome	1.43e-05	0.0125	CrCbGaD
Quazepam—Alprazolam—GABRB3—epilepsy syndrome	1.43e-05	0.0125	CrCbGaD
Quazepam—Alprazolam—GABRA5—epilepsy syndrome	1.43e-05	0.0125	CrCbGaD
Quazepam—Clonazepam—GABRB2—epilepsy syndrome	1.43e-05	0.0125	CrCbGaD
Quazepam—Prazepam—GABRG2—epilepsy syndrome	1.4e-05	0.0122	CrCbGaD
Quazepam—Clonazepam—GABRA1—epilepsy syndrome	1.4e-05	0.0122	CrCbGaD
Quazepam—Cinolazepam—GABRA5—epilepsy syndrome	1.39e-05	0.0122	CrCbGaD
Quazepam—Cinolazepam—GABRB3—epilepsy syndrome	1.39e-05	0.0122	CrCbGaD
Quazepam—Diazepam—GABRD—epilepsy syndrome	1.37e-05	0.012	CrCbGaD
Quazepam—Clotiazepam—GABRB2—epilepsy syndrome	1.32e-05	0.0116	CrCbGaD
Quazepam—Flunitrazepam—GABRA5—epilepsy syndrome	1.31e-05	0.0114	CrCbGaD
Quazepam—Flurazepam—GABRG2—epilepsy syndrome	1.3e-05	0.0114	CrCbGaD
Quazepam—Triazolam—GABRG2—epilepsy syndrome	1.3e-05	0.0114	CrCbGaD
Quazepam—Clotiazepam—GABRA1—epilepsy syndrome	1.3e-05	0.0114	CrCbGaD
Quazepam—Alprazolam—GABRB2—epilepsy syndrome	1.25e-05	0.0109	CrCbGaD
Quazepam—Temazepam—GABRG2—epilepsy syndrome	1.25e-05	0.0109	CrCbGaD
Quazepam—Alprazolam—GABRA1—epilepsy syndrome	1.23e-05	0.0107	CrCbGaD
Quazepam—Estazolam—GABRA5—epilepsy syndrome	1.22e-05	0.0107	CrCbGaD
Quazepam—Estazolam—GABRB3—epilepsy syndrome	1.22e-05	0.0107	CrCbGaD
Quazepam—Cinolazepam—GABRB2—epilepsy syndrome	1.22e-05	0.0107	CrCbGaD
Quazepam—Midazolam—GABRG2—epilepsy syndrome	1.21e-05	0.0106	CrCbGaD
Quazepam—Cinolazepam—GABRA1—epilepsy syndrome	1.19e-05	0.0105	CrCbGaD
Quazepam—Halazepam—GABRB3—epilepsy syndrome	1.19e-05	0.0104	CrCbGaD
Quazepam—Halazepam—GABRA5—epilepsy syndrome	1.19e-05	0.0104	CrCbGaD
Quazepam—Adinazolam—GABRA5—epilepsy syndrome	1.16e-05	0.0102	CrCbGaD
Quazepam—Adinazolam—GABRB3—epilepsy syndrome	1.16e-05	0.0102	CrCbGaD
Quazepam—Fludiazepam—GABRA5—epilepsy syndrome	1.15e-05	0.0101	CrCbGaD
Quazepam—Fludiazepam—GABRB3—epilepsy syndrome	1.15e-05	0.0101	CrCbGaD
Quazepam—Prazepam—GABRA5—epilepsy syndrome	1.13e-05	0.00985	CrCbGaD
Quazepam—Prazepam—GABRB3—epilepsy syndrome	1.13e-05	0.00985	CrCbGaD
Quazepam—Flunitrazepam—GABRA1—epilepsy syndrome	1.12e-05	0.00982	CrCbGaD
Quazepam—Estazolam—GABRB2—epilepsy syndrome	1.07e-05	0.00936	CrCbGaD
Quazepam—Estazolam—GABRA1—epilepsy syndrome	1.05e-05	0.00918	CrCbGaD
Quazepam—Flurazepam—GABRA5—epilepsy syndrome	1.05e-05	0.00918	CrCbGaD
Quazepam—Flurazepam—GABRB3—epilepsy syndrome	1.05e-05	0.00918	CrCbGaD
Quazepam—Triazolam—GABRA5—epilepsy syndrome	1.05e-05	0.00917	CrCbGaD
Quazepam—Triazolam—GABRB3—epilepsy syndrome	1.05e-05	0.00917	CrCbGaD
Quazepam—Halazepam—GABRB2—epilepsy syndrome	1.04e-05	0.0091	CrCbGaD
Quazepam—Diazepam—GABRG2—epilepsy syndrome	1.04e-05	0.00906	CrCbGaD
Quazepam—Halazepam—GABRA1—epilepsy syndrome	1.02e-05	0.00892	CrCbGaD
Quazepam—Adinazolam—GABRB2—epilepsy syndrome	1.02e-05	0.00891	CrCbGaD
Quazepam—Fludiazepam—GABRB2—epilepsy syndrome	1.01e-05	0.00883	CrCbGaD
Quazepam—Temazepam—GABRB3—epilepsy syndrome	1e-05	0.00878	CrCbGaD
Quazepam—Temazepam—GABRA5—epilepsy syndrome	1e-05	0.00878	CrCbGaD
Quazepam—Adinazolam—GABRA1—epilepsy syndrome	9.99e-06	0.00874	CrCbGaD
Quazepam—Fludiazepam—GABRA1—epilepsy syndrome	9.9e-06	0.00866	CrCbGaD
Quazepam—Prazepam—GABRB2—epilepsy syndrome	9.85e-06	0.00862	CrCbGaD
Quazepam—Midazolam—GABRA5—epilepsy syndrome	9.73e-06	0.00851	CrCbGaD
Quazepam—Midazolam—GABRB3—epilepsy syndrome	9.73e-06	0.00851	CrCbGaD
Quazepam—Prazepam—GABRA1—epilepsy syndrome	9.66e-06	0.00845	CrCbGaD
Quazepam—Flurazepam—GABRB2—epilepsy syndrome	9.19e-06	0.00804	CrCbGaD
Quazepam—Triazolam—GABRB2—epilepsy syndrome	9.17e-06	0.00803	CrCbGaD
Quazepam—Flurazepam—GABRA1—epilepsy syndrome	9.01e-06	0.00788	CrCbGaD
Quazepam—Triazolam—GABRA1—epilepsy syndrome	9e-06	0.00787	CrCbGaD
Quazepam—Temazepam—GABRB2—epilepsy syndrome	8.78e-06	0.00768	CrCbGaD
Quazepam—Temazepam—GABRA1—epilepsy syndrome	8.61e-06	0.00753	CrCbGaD
Quazepam—Midazolam—GABRB2—epilepsy syndrome	8.52e-06	0.00745	CrCbGaD
Quazepam—Midazolam—GABRA1—epilepsy syndrome	8.35e-06	0.00731	CrCbGaD
Quazepam—Diazepam—GABRB3—epilepsy syndrome	8.34e-06	0.00729	CrCbGaD
Quazepam—Diazepam—GABRA5—epilepsy syndrome	8.34e-06	0.00729	CrCbGaD
Quazepam—Diazepam—GABRB2—epilepsy syndrome	7.3e-06	0.00638	CrCbGaD
Quazepam—Diazepam—GABRA1—epilepsy syndrome	7.16e-06	0.00626	CrCbGaD
Quazepam—Clotiazepam—CYP2C19—epilepsy syndrome	6.1e-06	0.00534	CrCbGaD
Quazepam—Flunitrazepam—CYP2C19—epilepsy syndrome	5.27e-06	0.00461	CrCbGaD
Quazepam—Adinazolam—CYP2C19—epilepsy syndrome	4.7e-06	0.00411	CrCbGaD
Quazepam—Temazepam—CYP2C19—epilepsy syndrome	4.05e-06	0.00354	CrCbGaD
Quazepam—Clonazepam—ALB—epilepsy syndrome	3.64e-06	0.00319	CrCbGaD
Quazepam—Diazepam—CYP2C19—epilepsy syndrome	3.36e-06	0.00294	CrCbGaD
Quazepam—Flurazepam—ABCB1—epilepsy syndrome	2.24e-06	0.00196	CrCbGaD
Quazepam—Midazolam—ABCB1—epilepsy syndrome	2.08e-06	0.00182	CrCbGaD
Quazepam—Diazepam—ALB—epilepsy syndrome	1.87e-06	0.00163	CrCbGaD
Quazepam—Diazepam—ABCB1—epilepsy syndrome	1.78e-06	0.00156	CrCbGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.75e-06	6.91e-05	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.74e-06	6.88e-05	CbGpPWpGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.73e-06	6.84e-05	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.73e-06	6.84e-05	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	1.73e-06	6.83e-05	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	1.72e-06	6.81e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CA13—epilepsy syndrome	1.72e-06	6.81e-05	CbGpPWpGaD
Quazepam—GABRG3—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.7e-06	6.73e-05	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.7e-06	6.73e-05	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.69e-06	6.68e-05	CbGpPWpGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.68e-06	6.63e-05	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	1.67e-06	6.62e-05	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.66e-06	6.56e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	1.62e-06	6.4e-05	CbGpPWpGaD
Quazepam—GABRA1—Neuronal System—PRKCB—epilepsy syndrome	1.61e-06	6.34e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CA13—epilepsy syndrome	1.57e-06	6.21e-05	CbGpPWpGaD
Quazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	1.55e-06	6.11e-05	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.52e-06	6.01e-05	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	1.51e-06	5.98e-05	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	1.5e-06	5.95e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	1.49e-06	5.9e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	1.48e-06	5.87e-05	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	1.46e-06	5.78e-05	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.45e-06	5.74e-05	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.45e-06	5.73e-05	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.44e-06	5.68e-05	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.42e-06	5.63e-05	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.41e-06	5.58e-05	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.4e-06	5.53e-05	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.39e-06	5.5e-05	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.39e-06	5.5e-05	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.39e-06	5.48e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	1.39e-06	5.48e-05	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.38e-06	5.45e-05	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.37e-06	5.4e-05	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.37e-06	5.4e-05	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	1.36e-06	5.37e-05	CbGpPWpGaD
Quazepam—GABRR1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.36e-06	5.36e-05	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.35e-06	5.35e-05	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.34e-06	5.31e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	1.34e-06	5.29e-05	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.33e-06	5.28e-05	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.31e-06	5.18e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PDXK—epilepsy syndrome	1.31e-06	5.16e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—FAR1—epilepsy syndrome	1.31e-06	5.16e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—L2HGDH—epilepsy syndrome	1.31e-06	5.16e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ADK—epilepsy syndrome	1.31e-06	5.16e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GLUD1—epilepsy syndrome	1.31e-06	5.16e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CERS1—epilepsy syndrome	1.31e-06	5.16e-05	CbGpPWpGaD
Quazepam—GABRR2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.29e-06	5.11e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	1.26e-06	5e-05	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	1.25e-06	4.95e-05	CbGpPWpGaD
Quazepam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	1.25e-06	4.95e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—EPM2A—epilepsy syndrome	1.19e-06	4.72e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PNPO—epilepsy syndrome	1.19e-06	4.72e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—NHLRC1—epilepsy syndrome	1.19e-06	4.72e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GAMT—epilepsy syndrome	1.19e-06	4.72e-05	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.19e-06	4.72e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—FAR1—epilepsy syndrome	1.19e-06	4.7e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ADK—epilepsy syndrome	1.19e-06	4.7e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GLUD1—epilepsy syndrome	1.19e-06	4.7e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PDXK—epilepsy syndrome	1.19e-06	4.7e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—L2HGDH—epilepsy syndrome	1.19e-06	4.7e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CERS1—epilepsy syndrome	1.19e-06	4.7e-05	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.18e-06	4.68e-05	CbGpPWpGaD
Quazepam—GABRB3—BDNF signaling pathway—AKT1—epilepsy syndrome	1.16e-06	4.58e-05	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.15e-06	4.53e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—QDPR—epilepsy syndrome	1.11e-06	4.39e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CA4—epilepsy syndrome	1.11e-06	4.39e-05	CbGpPWpGaD
Quazepam—CYP2C19—Biological oxidations—POMC—epilepsy syndrome	1.11e-06	4.37e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GAMT—epilepsy syndrome	1.09e-06	4.3e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PNPO—epilepsy syndrome	1.09e-06	4.3e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—NHLRC1—epilepsy syndrome	1.09e-06	4.3e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—EPM2A—epilepsy syndrome	1.09e-06	4.3e-05	CbGpPWpGaD
Quazepam—GABRG3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.07e-06	4.21e-05	CbGpPWpGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.05e-06	4.15e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—COX3—epilepsy syndrome	1.04e-06	4.12e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.04e-06	4.09e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CA4—epilepsy syndrome	1.01e-06	4e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—QDPR—epilepsy syndrome	1.01e-06	4e-05	CbGpPWpGaD
Quazepam—CYP2C9—Biological oxidations—POMC—epilepsy syndrome	1.01e-06	3.99e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—SLCO1A2—epilepsy syndrome	9.89e-07	3.91e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PFKL—epilepsy syndrome	9.89e-07	3.91e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—KCNB1—epilepsy syndrome	9.89e-07	3.91e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—SLC6A8—epilepsy syndrome	9.89e-07	3.91e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CACNA2D2—epilepsy syndrome	9.89e-07	3.91e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	9.61e-07	3.8e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—COX3—epilepsy syndrome	9.52e-07	3.76e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—UPB1—epilepsy syndrome	9.05e-07	3.58e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ATIC—epilepsy syndrome	9.05e-07	3.58e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—NEU1—epilepsy syndrome	9.05e-07	3.58e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	9.02e-07	3.57e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	9.02e-07	3.57e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PFKL—epilepsy syndrome	9.02e-07	3.57e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	9.02e-07	3.57e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	9.02e-07	3.57e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	8.82e-07	3.48e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	8.76e-07	3.46e-05	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—ALB—epilepsy syndrome	8.71e-07	3.44e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—HSD17B4—epilepsy syndrome	8.71e-07	3.44e-05	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	8.55e-07	3.38e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GBE1—epilepsy syndrome	8.41e-07	3.32e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PPP1R3C—epilepsy syndrome	8.41e-07	3.32e-05	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	8.41e-07	3.32e-05	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	8.35e-07	3.3e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ATIC—epilepsy syndrome	8.25e-07	3.26e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—NEU1—epilepsy syndrome	8.25e-07	3.26e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—UPB1—epilepsy syndrome	8.25e-07	3.26e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	8.22e-07	3.25e-05	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	8.2e-07	3.24e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	7.94e-07	3.14e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ASAH1—epilepsy syndrome	7.91e-07	3.13e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	7.85e-07	3.1e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PDXK—epilepsy syndrome	7.85e-07	3.1e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	7.85e-07	3.1e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—FAR1—epilepsy syndrome	7.85e-07	3.1e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CERS1—epilepsy syndrome	7.85e-07	3.1e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ADK—epilepsy syndrome	7.85e-07	3.1e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—STXBP1—epilepsy syndrome	7.69e-07	3.04e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GBE1—epilepsy syndrome	7.67e-07	3.03e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	7.67e-07	3.03e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ALAD—epilepsy syndrome	7.5e-07	2.96e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—NT5E—epilepsy syndrome	7.5e-07	2.96e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	7.5e-07	2.96e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	7.21e-07	2.85e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	7.18e-07	2.84e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PNPO—epilepsy syndrome	7.18e-07	2.84e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GAMT—epilepsy syndrome	7.18e-07	2.84e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	7.18e-07	2.84e-05	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	7.17e-07	2.83e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ALDH7A1—epilepsy syndrome	7.15e-07	2.83e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CACNA1A—epilepsy syndrome	7.15e-07	2.83e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	7.02e-07	2.77e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ST3GAL3—epilepsy syndrome	7e-07	2.77e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ADSL—epilepsy syndrome	6.86e-07	2.71e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—NT5E—epilepsy syndrome	6.84e-07	2.7e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ALAD—epilepsy syndrome	6.84e-07	2.7e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GLUL—epilepsy syndrome	6.73e-07	2.66e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CA4—epilepsy syndrome	6.67e-07	2.64e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—QDPR—epilepsy syndrome	6.67e-07	2.64e-05	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	6.65e-07	2.63e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	6.6e-07	2.61e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	6.52e-07	2.58e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	6.52e-07	2.58e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	6.38e-07	2.52e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—COX3—epilepsy syndrome	6.28e-07	2.48e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ADSL—epilepsy syndrome	6.25e-07	2.47e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	6.17e-07	2.44e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GLUL—epilepsy syndrome	6.13e-07	2.42e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	6.02e-07	2.38e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—AQP1—epilepsy syndrome	5.99e-07	2.37e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	5.95e-07	2.35e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	5.95e-07	2.35e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PFKL—epilepsy syndrome	5.95e-07	2.35e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	5.95e-07	2.35e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	5.95e-07	2.35e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.76e-07	2.28e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	5.63e-07	2.22e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—AQP1—epilepsy syndrome	5.47e-07	2.16e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ATIC—epilepsy syndrome	5.44e-07	2.15e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—NEU1—epilepsy syndrome	5.44e-07	2.15e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—UPB1—epilepsy syndrome	5.44e-07	2.15e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	5.42e-07	2.14e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	5.42e-07	2.14e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.25e-07	2.07e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	5.24e-07	2.07e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	5.06e-07	2e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GBE1—epilepsy syndrome	5.06e-07	2e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.05e-07	2e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.95e-07	1.95e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	4.94e-07	1.95e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	4.94e-07	1.95e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	4.76e-07	1.88e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	4.63e-07	1.83e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.6e-07	1.82e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.51e-07	1.78e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—NT5E—epilepsy syndrome	4.51e-07	1.78e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ALAD—epilepsy syndrome	4.51e-07	1.78e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	4.42e-07	1.75e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	4.3e-07	1.7e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	4.3e-07	1.7e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	4.28e-07	1.69e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.25e-07	1.68e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	4.21e-07	1.66e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ADSL—epilepsy syndrome	4.12e-07	1.63e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4.04e-07	1.6e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	4.03e-07	1.59e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	3.97e-07	1.57e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	3.93e-07	1.55e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	3.9e-07	1.54e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.87e-07	1.53e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.87e-07	1.53e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	3.86e-07	1.53e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	3.71e-07	1.47e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	3.68e-07	1.45e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—BCHE—epilepsy syndrome	3.66e-07	1.45e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.6e-07	1.42e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.53e-07	1.4e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	3.52e-07	1.39e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	3.49e-07	1.38e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	3.46e-07	1.37e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—TH—epilepsy syndrome	3.44e-07	1.36e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.39e-07	1.34e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	3.35e-07	1.33e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—BCHE—epilepsy syndrome	3.34e-07	1.32e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.26e-07	1.29e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.26e-07	1.29e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	3.19e-07	1.26e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	3.15e-07	1.25e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—TH—epilepsy syndrome	3.14e-07	1.24e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.09e-07	1.22e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	2.87e-07	1.14e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CAT—epilepsy syndrome	2.84e-07	1.12e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	2.76e-07	1.09e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.66e-07	1.05e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	2.62e-07	1.04e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.59e-07	1.02e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CAT—epilepsy syndrome	2.59e-07	1.02e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.57e-07	1.02e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GPX1—epilepsy syndrome	2.56e-07	1.01e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	2.51e-07	9.94e-06	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GPX1—epilepsy syndrome	2.34e-07	9.24e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.32e-07	9.18e-06	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—AGT—epilepsy syndrome	2.25e-07	8.88e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.21e-07	8.74e-06	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—APOE—epilepsy syndrome	2.2e-07	8.71e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.2e-07	8.7e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.1e-07	8.3e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.08e-07	8.21e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—TH—epilepsy syndrome	2.07e-07	8.18e-06	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—AGT—epilepsy syndrome	2.05e-07	8.1e-06	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—APOE—epilepsy syndrome	2.01e-07	7.94e-06	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—POMC—epilepsy syndrome	1.89e-07	7.48e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.73e-07	6.83e-06	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.73e-07	6.82e-06	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.73e-07	6.82e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.7e-07	6.74e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.66e-07	6.55e-06	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.57e-07	6.22e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.54e-07	6.09e-06	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	1.51e-07	5.97e-06	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.38e-07	5.44e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.35e-07	5.34e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.32e-07	5.24e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.14e-07	4.5e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.04e-07	4.1e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	9.08e-08	3.59e-06	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—AKT1—epilepsy syndrome	7.59e-08	3e-06	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—AKT1—epilepsy syndrome	6.92e-08	2.73e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.56e-08	1.8e-06	CbGpPWpGaD
